PRP, PRF, and PRFM all begin with a blood sample, but the way that sample is processed changes the resulting preparation.
The main differences involve how platelets are concentrated, whether anticoagulants or activators are used, and how a fibrin network forms. These details matter more than calling one treatment a newer “generation” than another.
PRP: platelet-rich plasma
PRP is plasma containing a higher concentration of platelets than the starting blood sample. Platelets release growth factors and other signaling molecules involved in tissue repair.
Blood is typically collected with an anticoagulant to prevent premature clotting, then centrifuged to separate its components. Some protocols include an activation step before application.
PRP is not one standardized product. Platelet concentration, white blood cell content, red blood cell contamination, and preparation methods can vary. Two treatments both described as PRP may therefore differ substantially.
PRF: platelet-rich fibrin
PRF preparations incorporate platelets within, or in association with, a fibrin network. Fibrin is a protein involved in forming blood clots and provides a framework within healing tissue.
Many PRF protocols collect blood without an added anticoagulant, allowing clotting to develop during processing. Depending on the protocol, the resulting preparation may be a clot or membrane, or an initially injectable liquid that forms fibrin afterward.
Timing, collection tubes, and centrifugation conditions affect the result. PRF should not be described as having one fixed composition or growth-factor concentration.
PRFM: platelet-rich fibrin matrix
PRFM generally describes a preparation designed to retain platelets within a fibrin matrix. However, terminology and preparation methods vary between systems and publications.
Some PRFM systems begin with anticoagulated blood and use an activation step to form the matrix. It is therefore inaccurate to assume that every product called PRFM contains no additives or anticoagulants.
Ask which system is being used and how its preparation differs from the alternatives.
Does a fibrin matrix mean better results?
A fibrin network may influence how platelets and signaling molecules are retained and released. That is a reason to study these preparations—not proof that one consistently produces better cosmetic outcomes.
Clinical benefit depends on the concern being treated, the preparation, how it is administered, and the patient. Laboratory measurements cannot establish a universal ranking of PRP, PRF, and PRFM.
How are they used in aesthetics?
Researchers have investigated platelet preparations for concerns including facial skin quality, acne scars, under-eye changes, and certain types of hair loss.
The amount and quality of evidence differ by application. Results from a PRP study should not automatically be used to promise the same benefit from PRF or PRFM.
What should you ask before treatment?
Ask your provider to explain the exact preparation, why it is being recommended, what evidence supports it for your concern, and what improvement is realistic.
You should also understand the risks, recovery, proposed treatment schedule, and total cost. Using your own blood does not remove the need for informed consent or careful medical assessment.
The most useful comparison is the one that helps you choose an appropriate treatment for your goals—with a clear understanding of what is known and what remains uncertain.
Updated October 23, 2026.